Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies (vol 53, pg 687, 2023) - Nester, C; Appel, GB; Bomback, AS; Bouman, KP; Cook, HT; Daina, E; Dixon, BP; Rice, K; Najafian, N; Hui, J; Podos, SD; Langman, CB; et al. (AMERICAN JOURNAL OF NEPHROLOGY, 2023)